138 related articles for article (PubMed ID: 8521192)
21. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
22. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
Transfusion; 1997 Feb; 37(2):135-40. PubMed ID: 9051086
[TBL] [Abstract][Full Text] [Related]
23. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.
Bronspiegel-Weintrob N; Olivieri NF; Tyler B; Andrews DF; Freedman MH; Holland FJ
N Engl J Med; 1990 Sep; 323(11):713-9. PubMed ID: 2388669
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a reduction of growth potential in adolescent female gymnasts.
Theintz GE; Howald H; Weiss U; Sizonenko PC
J Pediatr; 1993 Feb; 122(2):306-13. PubMed ID: 8117341
[TBL] [Abstract][Full Text] [Related]
25. Short stature and body proportion in thalassaemia.
Caruso-Nicoletti M; De Sanctis V; Capra M; Cardinale G; Cuccia L; Di Gregorio F; Filosa A; Galati MC; Lauriola A; Malizia R; Mangiagli A; Massolo F; Mastrangelo C; Meo A; Messina MF; Ponzi G; Raiola G; Ruggiero L; Tamborino G; Saviano A
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():811-6. PubMed ID: 10091151
[TBL] [Abstract][Full Text] [Related]
26. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
Pomarède R; Girot R; Constant S; Rappaport R
Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
[TBL] [Abstract][Full Text] [Related]
27. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.
Soliman AT; El Banna N; Abdel Fattah M; ElZalabani MM; Ansari BM
Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744
[TBL] [Abstract][Full Text] [Related]
29. [Measurement of the secretion of growth hormone in patients with thalassemia major].
De Luca G; Maggiolini M; Bria M; Caracciolo M; Lanzino M; Le Pera M; Brancati C; Andò S
Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):62-5. PubMed ID: 7910656
[No Abstract] [Full Text] [Related]
30. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
[TBL] [Abstract][Full Text] [Related]
32. Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience.
Calleja EM; Shen JY; Lesser M; Grady RW; New MI; Giardina PJ
Ann N Y Acad Sci; 1998 Jun; 850():469-70. PubMed ID: 9668587
[No Abstract] [Full Text] [Related]
33. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
Chuansumrit A; Sirachainan N; Kitpoka P; Kadegasem P; Songdej D; Sasanakul W; Wongwerawattanakoon P
Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
[TBL] [Abstract][Full Text] [Related]
34. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.
De Sanctis V; Pinamonti A; Di Palma A; Sprocati M; Atti G; Gamberini MR; Vullo C
Eur J Pediatr; 1996 May; 155(5):368-72. PubMed ID: 8741032
[TBL] [Abstract][Full Text] [Related]
35. [Influence of different parameters on final height of boys with constitutional delay of growth and puberty].
Krajewska-Siuda E; Małecka-Tendera E; Krajewski-Siuda K
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):159-62. PubMed ID: 17020647
[TBL] [Abstract][Full Text] [Related]
36. Growth prognosis and growth after menarche in primary hypothyroidism.
Pantsiouou S; Stanhope R; Uruena M; Preece MA; Grant DB
Arch Dis Child; 1991 Jul; 66(7):838-40. PubMed ID: 1863095
[TBL] [Abstract][Full Text] [Related]
37. Growth and puberty and its management in thalassaemia.
De Sanctis V
Horm Res; 2002; 58 Suppl 1():72-9. PubMed ID: 12373018
[TBL] [Abstract][Full Text] [Related]
38. Treatment and complications of thalassemia major in Guangxi, Southern China.
Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
[TBL] [Abstract][Full Text] [Related]
39. Early puberty: rapid progression and reduced final height in girls with low birth weight.
Ibáñez L; Ferrer A; Marcos MV; Hierro FR; de Zegher F
Pediatrics; 2000 Nov; 106(5):E72. PubMed ID: 11061809
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease.
Mahachoklertwattana P; Chuansumrit A; Sirisriro R; Choubtum L; Sriphrapradang A; Rajatanavin R
Clin Endocrinol (Oxf); 2003 Mar; 58(3):273-9. PubMed ID: 12608931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
